Keyphrases
Multiple Sclerosis Treatment
100%
Dendritic Cells
100%
Progressive multiple Sclerosis
100%
Progressive MS
100%
Plasmacytoid DC
100%
Myeloid Dendritic Cells
100%
Interferon-β (IFN-β)
75%
CD86
50%
CD83
50%
MS Patients
50%
CD80
50%
CD123
50%
Beneficial Effects
25%
Multiple Sclerosis
25%
Flow Cytometry
25%
Healthy Controls
25%
Relapsing-remitting multiple Sclerosis
25%
CD40
25%
Impaired Maturation
25%
Immunology and Microbiology
Dendritic Cell
100%
Primary Progressive Multiple Sclerosis
100%
Maturation
100%
Myeloid Dendritic Cell
100%
Multiple Sclerosis
50%
CD86
50%
CD83
50%
CD80
50%
Secondary Progressive Multiple Sclerosis
25%
Relapsing Remitting Multiple Sclerosis
25%
Beta Interferon
25%
Neuroscience
Myeloid
100%
Primary Progressive Multiple Sclerosis
100%
Multiple Sclerosis
50%
CD86
50%
CD80
50%
Relapsing Remitting Multiple Sclerosis
25%
Secondary Progressive Multiple Sclerosis
25%
Beta Interferon
25%
Flow Cytometry
25%